Шифр: CS5/2009/64/6 Журнал 2009р. Vol. 64 N 6 In vitro assessment of novel transcription inhibitors and topoisomerase poisons in rhabdomyosarcoma cell lines. - P.1059-1069 Інші автори: , , Wolf S. J., Wakelin L. P.G., He Z., Stewart B. W., Catchpoole D. R. A phase I study of palliative chemoradiation therapy with paclitaxel and cisplatin for local symptoms due to an unresectable primary advanced or locally recurrent gastric adenocarcinoma. - P.1071-1077 Інші автори: , , Yoshikawa T., Tsuburaya A., Hirabayashi N., Yoshida K., Nagata N., Kodera Y., Takahashi N., Oba K., Kimura M., Ishikura S., Miyashita Y., Sakamoto J. Preliminary results of M-VAC chemotherapy combined with mild hyperthermia, a new therapeutic strategy for advanced or metastatic transitional cell carcinoma of the urothelium. - P.1079-1083 Інші автори: , , Yamada Y., Itoh Y., Aoki S., Nakamura K., Taki T., Naruse K., Tobiume M., Zennami K., Katsuda R., Kato Y., Watanabe M., Nishikawa G., Minami M., Nakahira M., Ukai S., Sawada M., Kitamura A., Honda N. Pre-clinical evaluation of Rh2 in PC-3 human xenograft model for prostate cancer in vivo: formulation, pharmacokinetics, biodistribution and efficacy. - P.1085-1095 Інші автори: , , Musende A.G., Eberding A., Wood C., Adomat H., Fazli L., Hurtado-Coll A., Jia W., Bally M. B., Guns E. T. Panaxadiol, a purified ginseng component, enhances the anti-cancer effects of 5-fluorouracil in human colorectal cancer cells. - P.1097-1104 Інші автори: , , Li X.-L., Wang C.-Z., Mehendale S. R., Sun S., Wang Q., Yuan C.-S. Endurance exercise training preserves cardiac function in rats receiving doxorubicin and the HER-2 inhibitor GW2974. - P.1105-1113 Інші автори: , , Wonders K. Y., Hydock D. S., Greufe S., Schneider C. M., Hayward R. Enhancement of cisplatin cytotoxicity by SAHA involves endoplasmic reticulum stress-mediated apoptosis in oral squamous cell carcinoma cells. - P.1115-1122 Інші автори: , , Suzuki M., Endo M., Shinohara F., Echigo S., Rikiishi H. Erlotinib in advanced non-small-cell lung cancer after gefitinib failure. - P.1123-1127 Інші автори: , , Zhou Z.-T., Xu X.-H., Wei Q., Lu M.-q., Wang J., Wen C.-H. Schedule-dependent synergism and antagonism between pemetrexed and docetaxel in human lung cancer cell lines in vitro. - P.1129-1137 Інші автори: , , Kano Y., Tanaka M., Akutsu M., Mori K., Yazawa Y., Mano H., Furukawa Y. A randomized, phase II, dose-finding study of the pan-ErbB receptor tyrosine-kinase inhibitor CI-1033 in patients with pretreated metastatic breast cancer. - P.1139-1148 Інші автори: , , Rixe O., Franco S. X., Yardley D. A., Johnston S. R., Martin M., Arun B. K., Letrent S. P., Rugo H. S. Phase I trial of GTI-2040, oxaliplatin, and capecitabine in the treatment of advanced metastatic solid tumors: a California Cancer Consortium Study. - P.1149-1155 Інші автори: , , Shibata S. I., Doroshow J. H., Frankel P., Synold T. W., Yen Y., Gandara D. R., Lenz H.-J., Chow W. A., Leong L. A., Lim D., Margolin K. A., Morgan R. J., Somlo G., Newman E. M. Antineoplastic activity of idazoxan hydrochloride. - P.1157-1163 Інші автори: , , Eilon G. F., Weisenthal L., Stupecky M., Landucci G., Slater L. M. Phase I, dose escalation and pharmacokinetic study of cediranib (RECENTIN™), a highly potent and selective VEGFR signaling inhibitor, in Japanese patients with advanced solid tumors. - P.1165-1172 Інші автори: , , Yamamoto N., Tamura T., Yamamoto N., Yamada K., Yamada Y., Nokihara H., Fujiwara Y., Takahashi T., Murakami H., Boku N., Yamazaki K., Puchalski T. A., Shin E. Phase II study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of 5-fluorouracil/leucovorin (GOFL) in advanced pancreatic cancer. - P.1173-1179 Інші автори: , , Ch’ang H.-J., Huang C.-L., Wang H.-P., Shiah H.-S., Chang M.-C., Jan C.-M., Chen J.-S., Tien Y.-W., Hwang T.-L., Lin J.-T., Cheng A.-L., Whang-P. J., Chen L.T. A phase II study of S-1 monotherapy as second-line treatment for advanced non-small cell lung cancer. - P.1181-1185 Інші автори: , , Totani Y., Saito Y., Hayashi M., Tada T., Kohashi Y., Mieno Y., Kato A., Imizu H., Yoneda Y., Hoshino T., Uchiyama Y., Takeuchi Y., Okazawa M., Sakakibara H. Expression of Na,K-ATPase-beta1 subunit increases uptake and sensitizes carcinoma cells to oxaliplatin. - P.1187-1194 Інші автори: , , Tummala R., Wolle D., Barwe S. P., Sampson V. B., Rajasekaran A. K., Pendyala L. Thymidylate synthetase allelic imbalance in clear cell renal carcinoma. - P.1195-1200 Інші автори: , , Colavito D., Cartei G., Bianco M. D., Stecca A., Zustovich F., Carbonare M. D., Ragazzi E., Farina M., Colombrino E., Leon A. Thalidomide suppressed the growth of 4T1 cells into solid tumors in Balb/c mice in a combination therapy with the oncolytic fusogenic HSV-1 OncdSyn. - P.1201-1210 Інші автори: , , Israyelyan A., Shannon E. J., Baghian A., Kearney M. T., Kousoulas K. G. Experimental study of combination therapy with S-1 against pancreatic cancer. - P.1211-1219 Інші автори: , , Yoshizawa J., Takizawa A., Takeuchi O., Hiraku O., Sasaki K., Morimoto Y., Atsuda K., Inoue G., Suzuki Y., Asanuma F., Yamada Y. Antiangiogenic and antiproliferative effects of substituted-1,3,4-oxadiazole derivatives is mediated by down regulation of VEGF and inhibition of translocation of HIF-1α in Ehrlich ascites tumor cells. - P.1221-1233 Інші автори: , , Kumar A., D’Souza S. S., Nagaraj S. R. M., Gaonkar S. L., Salimath B. P., Rai K. M. L. Pyrrolotetrazinones deazaanalogues of temozolomide induce apoptosis in Jurkat cell line: involvement of tubulin polymerization inhibition. - P.1235-1251 Інші автори: , , Viola G., Cecconet L., Leszl A., Basso G., Brun P., Salvador A., Dall’Acqua F., Diana P., Barraja P., Cirrincione G. Outcome of upfront combination chemotherapy followed by chemoradiation for locally advanced pancreatic adenocarcinoma. - P.1253-1259 Інші автори: , , Cereda S., Balzano G., Passoni P., Rognone A., Zerbi A., Nicoletti R., Mazza E., Arcidiacono P. G., Carlo V. D., Villa E. Pharmacokinetics and metabolism of the putative cancer chemopreventive agent cyanidin-3-glucoside in mice. - P.1261-1268 Інші автори: , , Marczylo T. H., Cooke D., Brown K., Steward W. P., Gescher A. J. Є примірники у відділах: всього 1 : ВКТ (1) Вільні: ВКТ (1) |